Company: Silexion Therapeutics Corp

Form Type: 8-K

Filing Date: 2024-08-21

Corporate Action: Spin-off

Type: New

Accession Number: 000121390024071491

Comments: The document discusses a business combination between Silexion Therapeutics Corp and Moringa Acquisition Corp, rather than a spin-off. The transaction involves a merger and does not indicate any percentage of an existing company being spun off or details on parent and new company CIKs.

Document Link: View Document